113 related articles for article (PubMed ID: 34319476)
21. ASO Author Reflections: How Can We Improve Quality of Cancer Treatment at Community Hospitals?
Tucker TC; Mullett TW
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):871-872. PubMed ID: 32761332
[No Abstract] [Full Text] [Related]
22. ASO Author Reflections: Hospital Volume, Cancer Outcomes and Access to Specialized Care.
Baumrucker CC; Macedo FI
Ann Surg Oncol; 2021 Apr; 28(4):2136-2137. PubMed ID: 32960393
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: Commission on Cancer Accreditation as an Independent Predictor of Cancer Survival.
Ahmed A; Whittington J; Shafaee Z
Ann Surg Oncol; 2024 Apr; 31(4):2303. PubMed ID: 38142254
[No Abstract] [Full Text] [Related]
24. ASO Author Reflections: Improving Our Understanding of Socioeconomic Disparities in Cancer Treatment and Outcomes.
Hoehn RS; Rieser CJ; Zureikat AH
Ann Surg Oncol; 2021 May; 28(5):2447-2448. PubMed ID: 33523365
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: How Do Patients and Caregivers Select Hospitals for Complex Cancer Care?
Fong ZV; Traeger L
Ann Surg Oncol; 2021 Aug; 28(8):4193-4194. PubMed ID: 33423124
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Bridging the Gap between Clinical Trial Data and Real-World Cancer Care.
Boughey JC; Francescatti AB; Park KU; Hunt KK
Ann Surg Oncol; 2020 Jul; 27(7):2276-2277. PubMed ID: 32372313
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Better Understanding of What We Have Learned from Cancer Care Quality Metrics.
Shulman LN
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):641-642. PubMed ID: 31214848
[No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Influence of Patient Clinical- and Treatment-Level Factors on Religious/Spiritual Preferences During Cancer Care.
Palmer Kelly E; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):753-754. PubMed ID: 32436186
[No Abstract] [Full Text] [Related]
29. ASO Author Reflections: Radiopathomics Strategy of Combing Multi-scale Tumor Information on Pretreatment to Predict the Pathologic Response to Neoadjuvant Therapy.
Tian J; Fan X; Xu R; Sun YS; Yang G
Ann Surg Oncol; 2020 Oct; 27(11):4307-4308. PubMed ID: 32495287
[No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors.
Massironi S; Rossi RE
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):858-859. PubMed ID: 30145647
[No Abstract] [Full Text] [Related]
31. ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications.
Dumitra S; Lee B
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):557-558. PubMed ID: 30600405
[No Abstract] [Full Text] [Related]
32. ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors.
Cloyd JM; Poultsides GA
Ann Surg Oncol; 2021 Feb; 28(2):1050-1051. PubMed ID: 32974698
[No Abstract] [Full Text] [Related]
33. ASO Author Reflections: Cytoreduction for Extrahepatic Metastatic Neuroendocrine Tumors.
Chan DL; Hallet J
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):866-867. PubMed ID: 30306370
[No Abstract] [Full Text] [Related]
34. ASO Author Reflections: The Significance of Tumor Rupture in Gastric Gastrointestinal Stromal Tumors.
Hølmebakk T
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):928-929. PubMed ID: 30327974
[No Abstract] [Full Text] [Related]
35. ASO Author Reflections: Remote Home Monitoring After Surgery: Focus on Feasibility for Older Cancer Patients.
Jonker LT; Lahr MMH
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):789-790. PubMed ID: 32588262
[No Abstract] [Full Text] [Related]
36. ASO Author Reflections: Clinical Significance of Peripheral Blood Inflammatory Markers in Thymic Epithelial Tumors.
Okada S; Inoue M
Ann Surg Oncol; 2020 Jul; 27(7):2448-2449. PubMed ID: 32198568
[No Abstract] [Full Text] [Related]
37. [The present and future of National Clinical Database].
Iwanaka T
Nihon Geka Gakkai Zasshi; 2013 Jul; 114(4):169. PubMed ID: 23898701
[No Abstract] [Full Text] [Related]
38. ASO Author Reflections: Contact Between T and N Classifications in Pancreatic Neuroendocrine Neoplasms.
Xu JZ; Wang WQ; Liu L; Yu XJ
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):814-815. PubMed ID: 30302639
[No Abstract] [Full Text] [Related]
39. ASO Author Reflections: Breast Angiosarcoma-A Rare Disease with a Lot of Uncertainty.
Friedrich AU; Lannin DR
Ann Surg Oncol; 2021 Sep; 28(9):5119-5120. PubMed ID: 33620617
[No Abstract] [Full Text] [Related]
40. ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors.
Gaitanidis A; Patel D; Kebebew E
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):874-875. PubMed ID: 30353397
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
